| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 2.1 | 2.3 |
| Total income | 2.1 | 2.1 | 2.3 |
| Profit before exceptional items & tax | -0.5 | -0.0 | 0.1 |
| Exceptional items | 0.3 | 0.3 | 0.1 |
| Profit before tax | -0.2 | 0.3 | 0.2 |
| Net profit | -0.1 | 0.2 | 0.3 |
| Operating margin | -9.5% | 14.3% | 8.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -8.70% |
|---|
Source
Read the filing ↗
BSE results filing, BSE: 541299. Figures extracted from the filing.
Dr. Lalchandani Labs Ltd: key numbers
- Share price
- ₹7.25
- Market cap
- ₹6.28 Cr
- Revenue (annual)
- ₹4.19 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 98.8×Sector 57.8×
- Promoter holding
- 32.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lalchandani Labs Ltd
All →
20:27 IST
BSE
Other Announcement
Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.